We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

The wages of complexity

9 June 2010 By Robert Cyran

Eclipsys investors score a 19 pct premium, while cost cuts and potential revenue gains should benefit seller and buyer Allscripts alike in the $1.3 bln allshare transaction. There are some ifs, but not for Misys. It cashes out of its majority Allscripts stake for a fat return.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)